Imagen de perfil
Have you ever made a comparison with $EUZ? I would actually consider them to be ahead in the field of radiopharmaceuticals and diagnostics🤔.
•
1
•
Imagen de perfil
@All-in-or-nothing I had Eckert & Ziegler in my portfolio and then sold it in the summer with a 39% gain.
So yes, I know it well. The setback was not enough for me to get back in
•
1
•